Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study.
Papa A, Scaldaferri F, Covino M, Tursi A, Furfaro F, Mocci G, Lopetuso LR, Maconi G, Bibbò S, Fiorani M, Laterza L, Mignini I, Napolitano D, Parisio L, Pizzoferrato M, Privitera G, Pugliese D, Schepis T, Schiavoni E, Settanni CR, Vetrone LM, Armuzzi A, Danese S, Gasbarrini A.
Papa A, et al. Among authors: mignini i.
Biomedicines. 2022 Apr 3;10(4):843. doi: 10.3390/biomedicines10040843.
Biomedicines. 2022.
PMID: 35453593
Free PMC article.